secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001193125-22-097657
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD completes spinoff of Diabetes Care business as Embecta Corp. (EMBC)
----------------------------------------------------------------------

- Shareholders receive one share of embecta for every five BD shares held as of March 22, 2022.
- BD retains no ownership; embecta begins trading on NASDAQ under ticker EMBC.
- Two BD directors (Claire Pomeroy, David Melcher) resign to join embecta board; BD board reduced to 11.
- embecta issued $200M 6.750% senior secured notes due 2030 to BD; BD exchanged for $199M floating-rate notes.
- BD guaranteed embecta credit facility and senior notes; guarantee automatically released upon separation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/0001193125-22-097657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/d328383d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-097657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer